collagen osteoporosis

Introduction

Osteoporosis is a chronic condition characterized by reduced bone mass and deterioration of bone tissue, leading to increased fracture risk. Collagen, a primary structural protein in bones, plays a crucial role in maintaining bone strength and quality. This synthesis explores the relationship between collagen and osteoporosis, focusing on genetic factors, biochemical changes, and potential therapeutic approaches.

Key Insights

Genetic Factors and Collagen in Osteoporosis
- The COL1A1 Sp1 polymorphism is associated with reduced bone strength and increased fracture risk due to changes in bone mass and quality.
- Mutations in the COL1A2 gene, similar to those causing osteogenesis imperfecta, have been identified in postmenopausal women with osteoporosis, suggesting a genetic overlap between the two conditions.
Biochemical Changes in Collagen
- Osteoporotic bones exhibit significant alterations in collagen, including increased hydroxylation of lysine residues and changes in stabilizing cross-links, which contribute to bone fragility .
- The concentration of collagen cross-links, particularly divalent reducible cross-links, is reduced in osteoporotic bones, leading to decreased bone strength despite normal collagen density.
- Increased metabolism of bone collagen in osteoporotic patients results in higher levels of post-translational modifications, making the bone matrix more fragile.
Collagen Cross-Links and Bone Quality
- Collagen cross-linking affects the mechanical properties of bone, with abnormalities in cross-links contributing to bone fragility in osteoporosis.
- The quality of bone collagen, including the type and extent of cross-linking, is crucial for bone strength and is altered in osteoporotic patients.
Potential Therapeutic Approaches
- Hydrolyzed collagen (HC) may benefit bone health by providing essential building blocks and regulatory functions, potentially serving as a nutritional approach to manage osteoporosis.
- The hypothesis that changes in skin collagen reflect changes in bone collagen suggests that treatments improving skin collagen, such as androgen or growth hormone, could also benefit bone density and strength.

Conclusion

The relationship between collagen and osteoporosis is multifaceted, involving genetic predispositions, biochemical alterations, and potential therapeutic interventions. Genetic mutations in collagen-related genes can predispose individuals to osteoporosis, while biochemical changes in collagen structure and cross-linking contribute to bone fragility. Therapeutic approaches, including dietary supplementation with hydrolyzed collagen and treatments targeting collagen metabolism, hold promise for improving bone health and managing osteoporosis.

Try another search

Does sampling period change difference in difference modeling outcomes

Does red meat cause cancer

Is Caffeine chromosomal mutagen

What is the impact of porosity on the performance of dye-sensitized solar cells (DSSC)?

peculiarities of code switching in German-speaking Switzerland

assertive intention in secondhand smoke really matters?

Collagen osteoporosis

Summary

Introduction

Key Insights

Conclusion

Sources and full results

A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.

The COL1A1 Sp1 polymorphism predisposes to osteoporosis through complex mechanisms involving changes in bone mass and bone quality.

Post-translational modifications in the collagen of human osteoporotic femoral head.

Post-translational modifications in collagen contribute to the fragility of osteoporotic bone, potentially playing a role in the pathogenesis of osteoporosis.

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

Collagen cross-links play a crucial role in bone quality and fragility, with age-related changes and abnormalities in cross-links potentially contributing to osteoporosis and diabetes-related fracture risk.

Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis.

Osteoporotic individuals have increased extractability and a reduced concentration of divalent reducible collagen cross links, potentially reducing bone strength and explaining fractures despite similar bone density.

Increased metabolism of bone collagen in post-menopausal female osteoporotic femoral heads.

Increased bone collagen metabolism in osteoporosis leads to more fragile bone matrix, highlighting the importance of bone quality beyond just bone density.

Osteoporosis, a unitary hypothesis of collagen loss in skin and bone.

The loss of collagen in skin and bones with aging is the causal counterpart to bone density loss in senile osteoporosis, suggesting that skin collagen could predict bone health and response to treatment.

Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.

There may be phenotypic and genotypic overlap between mild osteogenesis imperfecta and postmenopausal osteoporosis, suggesting a subset of women may have mutations in type I procollagen genes.

Collagen XIII-derived ectodomain regulates bone angiogenesis and intracortical remodeling.

Collagen XIII plays a role in age-dependent cortical bone deterioration, potentially impacting osteoporosis and fracture risk.

Biological effect of hydrolyzed collagen on bone metabolism

Hydrolyzed collagen may provide benefits for bone metabolism and may be a relevant alternative in future nutritional approaches for osteoporosis prevention.

Biochemical changes in the collagen of human osteoporotic bone matrix.

Osteoporotic bone collagen shows significant changes in properties and post-translational modifications, which may contribute to the pathogenesis of osteoporosis.

Try another search